{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:55:18Z","timestamp":1790510118756,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2515\/therapie\/2015053","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T06:39:45Z","timestamp":1444977585000},"page":"S31-S40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["Atteintes musculaires et levure de riz rouge\u00a0: analyse des donn\u00e9es de la base nationale de pharmacovigilance et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"78","author":[{"given":"Christelle","family":"Philibert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Bres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e8phe","family":"Jean-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Hillaire-Buys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2015053_bib0220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ctim.2012.07.004","article-title":"The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders","volume":"20","author":"Yang","year":"2012","journal-title":"Complement Ther Med"},{"key":"10.2515\/therapie\/2015053_bib0225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jada.2010.12.009","article-title":"Is red yeast rice safe and effective for lowering serum cholesterol?","volume":"111","author":"Cunningham","year":"2011","journal-title":"J Am Diet Assoc"},{"key":"10.2515\/therapie\/2015053_bib0230","series-title":"Fang Mei's illustrated cookbook of regional Chinese cuisine","first-page":"177","article-title":"Red yeast flavored duck","author":"Mei","year":"1990"},{"key":"10.2515\/therapie\/2015053_bib0235","unstructured":"Synadiet. D\u00e9tails des chiffres cl\u00e9s\u00a02013, par circuit de distribution et par segments de march\u00e9. http:\/\/www.synadiet.org\/sites\/default\/files\/page\/files\/synadiet_chiffres_ca2013.pdf [Consult\u00e9 le 7\u00a0juillet\u00a02015, 12\u00a0p.]."},{"key":"10.2515\/therapie\/2015053_bib0240","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/archinternmed.2010.382","article-title":"Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!","volume":"170","author":"Gordon","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie\/2015053_bib0245","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","article-title":"Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia","volume":"153","author":"Lin","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.2515\/therapie\/2015053_bib0250","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/00007890-200210270-00028","article-title":"Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient","volume":"74","author":"Prasad","year":"2002","journal-title":"Transplantation"},{"key":"10.2515\/therapie\/2015053_bib0255","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/01.SMJ.0000100117.79718.DC","article-title":"Chinese red rice-induced myopathy","volume":"96","author":"Smith","year":"2003","journal-title":"South Med J"},{"key":"10.2515\/therapie\/2015053_bib0260","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-145-6-200609190-00021","article-title":"Symptomatic myopathy due to red yeast rice","volume":"145","author":"Mueller","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie\/2015053_bib0265","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1532-5415.2006.00668_7.x","article-title":"Chinese red rice depletes muscle coenzyme\u00a0Q10\u00a0and maintains muscle damage after discontinuation of statin treatment","volume":"54","author":"Vercelli","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.2515\/therapie\/2015053_bib0270","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2125.2008.03224.x","article-title":"Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian surveillance system of natural health products","volume":"66","author":"Lapi","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie\/2015053_bib0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacl.2007.12.005","article-title":"A case report of myopathy from consumption of red yeast rice","volume":"2","author":"Polsani","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.2515\/therapie\/2015053_bib0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","article-title":"HypoCol (red yeast rice) lowers plasma cholesterol \u2013 a randomized placebo controlled study","volume":"44","author":"Bogsrud","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"10.2515\/therapie\/2015053_bib0285","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","article-title":"Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement","volume":"69","author":"Heber","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.2515\/therapie\/2015053_bib0290","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.2515\/therapie\/2015053_bib0295","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1472-6882-13-178","article-title":"Red yeast rice lowers cholesterol in physicians \u2013 a double blind, placebo controlled randomized trial","volume":"13","author":"Verhoeven","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"10.2515\/therapie\/2015053_bib0300","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial","volume":"150","author":"Becker","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie\/2015053_bib0305","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4065\/83.7.758","article-title":"Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial","volume":"83","author":"Becker","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.2515\/therapie\/2015053_bib0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ctim.2005.07.008","article-title":"Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study","volume":"13","author":"Cicero","year":"2005","journal-title":"Complement Ther Med"},{"key":"10.2515\/therapie\/2015053_bib0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10157-008-0033-x","article-title":"Efficacy and safety of Monascus purpureus Went rice in subjects with secondary hyperlipidemia","volume":"12","author":"Gheith","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.2515\/therapie\/2015053_bib0320","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2400mg twice daily) versus pravastatin (20mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.2515\/therapie\/2015053_bib0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1752-1947-4-4","article-title":"An alternative treatment of hyperlipidemia with red yeast rice: a case report","volume":"4","author":"Lin","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.2515\/therapie\/2015053_bib0330","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/0022-3859.90085","article-title":"Statin intolerance: now a solved problem","volume":"57","author":"Sikka","year":"2011","journal-title":"J Postgrad Med"},{"key":"10.2515\/therapie\/2015053_bib0335","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/jc.2009-2689","article-title":"Approach to the patient who is intolerant of statin therapy","volume":"95","author":"Eckel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2515\/therapie\/2015053_bib0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1749-8546-7-8","article-title":"NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements","volume":"7","author":"Lachenmeier","year":"2012","journal-title":"Chin Med"},{"key":"10.2515\/therapie\/2015053_bib0345","doi-asserted-by":"crossref","first-page":"e98611","DOI":"10.1371\/journal.pone.0098611","article-title":"A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia","volume":"9","author":"Li","year":"2014","journal-title":"Plos One"},{"key":"10.2515\/therapie\/2015053_bib0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/107555301750164181","article-title":"An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents","volume":"7","author":"Heber","year":"2001","journal-title":"J Altern Complement Med"},{"key":"10.2515\/therapie\/2015053_bib0355","first-page":"313","article-title":"Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia","volume":"34","author":"Klimek","year":"2009","journal-title":"P T"},{"key":"10.2515\/therapie\/2015053_bib0360","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.foodchem.2012.10.104","article-title":"Simultaneous determination of lovastatin and citrinin in red yeast rice supplements by micellar electrokinetic capillary chromatography","volume":"138","author":"Nigovic","year":"2013","journal-title":"Food Chem"},{"key":"10.2515\/therapie\/2015053_bib0365","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2009.02.021","article-title":"Acute hepatitis caused by a natural lipid-lowering product: when \u201calternative\u201d medicine is no \u201calternative\u201d at all","volume":"50","author":"Grieco","year":"2009","journal-title":"J Hepatol"},{"key":"10.2515\/therapie\/2015053_bib0370","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpba.2014.07.039","article-title":"Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application","volume":"100","author":"Avula","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.2515\/therapie\/2015053_bib0375","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-011-0232-9","article-title":"Update on toxic myopathies","volume":"12","author":"Mastaglia","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.2515\/therapie\/2015053_bib0380","series-title":"Goodman and Gilman's: the pharmacological basis of therapeutics","first-page":"895","author":"Gilman","year":"2011"},{"key":"10.2515\/therapie\/2015053_bib0385","doi-asserted-by":"crossref","first-page":"127043","DOI":"10.1155\/2012\/127043","article-title":"Interaction between red yeast rice and CYP450\u00a0enzymes\/P-glycoprotein and its implication for the clinical pharmacokinetics of lovastatin","volume":"2012","author":"Chen","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.2515\/therapie\/2015053_bib0390","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2009.11.033","article-title":"The genetics of statin-induced myopathy","volume":"210","author":"Ghatak","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.2515\/therapie\/2015053_bib0395","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/BF02088142","article-title":"Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin","volume":"39","author":"Grimbert","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.2515\/therapie\/2015053_bib0400","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-149-7-200810070-00021","article-title":"Symptomatic hepatitis associated with the use of herbal red yeast rice","volume":"149","author":"Roselle","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie\/2015053_bib0405","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.2515\/therapie\/2015053_bib0410","first-page":"2013","article-title":"Peripheral neuropathy induced by red yeast rice in a patient with a known small bowel gastrointestinal tumour","author":"Kumari","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.2515\/therapie\/2015053_bib0415","first-page":"58","article-title":"Case report. Monascus purpureus \u2013 a new fungus of allergologic relevance","volume":"45","author":"Hipler","year":"2002","journal-title":"Mycoses"},{"key":"10.2515\/therapie\/2015053_bib0420","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1034\/j.1398-9995.1999.00374.x","article-title":"Anaphylaxis due to Monascus purpureus-fermented rice (red yeast rice)","volume":"54","author":"Wigger-Alberti","year":"1999","journal-title":"Allergy"},{"key":"10.2515\/therapie\/2015053_bib0425","unstructured":"ANSM. Compl\u00e9ments alimentaires \u00e0 base de levure de riz rouge\u00a0: mises en garde de l\u2019ANSM \u2013 Point d\u2019information 14\/02\/2013. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Complements-alimentaires-a-base-de-levure-de-riz-rouge-mises-en-garde-de-l-ANSM-Point-d-information. [Consult\u00e9 le 7\u00a0juillet\u00a02015]."},{"key":"10.2515\/therapie\/2015053_bib0215","unstructured":"Anses. Avis de l\u2019Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail relatif aux risques li\u00e9s \u00e0 la pr\u00e9sence de \u00ab\u00a0levure de riz rouge\u00a0\u00bb dans les compl\u00e9ments alimentaires. 14\/02\/2014. https:\/\/www.anses.fr\/sites\/default\/files\/documents\/NUT2012sa0228.pdf. [Consult\u00e9 le 7\u00a0juillet\u00a02015 (34\u00a0pp.)]."}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716300543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716300543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T05:26:02Z","timestamp":1697088362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716300543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0040595716300543"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015053","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteintes musculaires et levure de riz rouge\u00a0: analyse des donn\u00e9es de la base nationale de pharmacovigilance et revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2515\/therapie\/2015053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}